by Jean Sung, PhD, Director, Pharmaceutical Development, Pulmatrix Inc | 11 May 2012
Pulmatrix highlights a novel dry powder delivery platform that offers the potential to enhance drug delivery via powder inhalation. Laser diffraction is applied to understand the dispersion properties of potential new formulations,
